{
  "paper_metadata": {
    "pmid": "27992035",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant Val30Met, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.90G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 18,
        "demographics": "Not specified",
        "phenotype": "Familial amyloidosis, including cardiac and extracardiac manifestations"
      },
      "penetrance_data": {
        "total_carriers_observed": 18,
        "affected_count": 10,
        "unaffected_count": 8,
        "uncertain_count": null,
        "penetrance_percentage": 55.56,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis",
          "evidence_sentence": "Patients were divided into three groups: 1- Val30Met with cardiac amyloidosis; 2-Val30Met with extracardiac amyloidosis; 3 - Val30Met without evidence of disease."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Extracardiac amyloidosis",
          "evidence_sentence": "Patients were divided into three groups: 1- Val30Met with cardiac amyloidosis; 2-Val30Met with extracardiac amyloidosis; 3 - Val30Met without evidence of disease."
        },
        {
          "individual_id": "Case_3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "unaffected",
          "phenotype_details": "No evidence of amyloidosis",
          "evidence_sentence": "Patients were divided into three groups: 1- Val30Met with cardiac amyloidosis; 2-Val30Met with extracardiac amyloidosis; 3 - Val30Met without evidence of disease."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation is associated with familial amyloidosis, affecting cardiac and extracardiac tissues.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families, as indicated by the grouping of patients based on disease presentation.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 1",
      "additional_notes": "The study highlights the importance of echocardiography in diagnosing early stages of familial amyloidosis caused by the Val30Met mutation.",
      "key_quotes": [
        "The most common type of familial amyloidosis is mediated by mutation of transthyretin, especially Val30Met.",
        "Patients were divided into three groups: 1- Val30Met with cardiac amyloidosis; 2-Val30Met with extracardiac amyloidosis; 3 - Val30Met without evidence of disease."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR gene variant Val30Met was extracted successfully."
  }
}